期刊文献+
共找到232篇文章
< 1 2 12 >
每页显示 20 50 100
Research progress of in-situ gelling ophthalmic drug delivery system 被引量:11
1
作者 Yumei Wu Yuanyuan Liu +7 位作者 Xinyue Li Dereje Kebebe Bing Zhang Jing Ren Jun Lu Jiawei Li Shouying Du Zhidong Liu 《Asian Journal of Pharmaceutical Sciences》 SCIE 2019年第1期1-15,I0001,共16页
Blindness and vision impairment are the most devastating global health problems resulting in a substantial economic and social burden.Delivery of drug to particular parts of the anterior or posterior segment has been ... Blindness and vision impairment are the most devastating global health problems resulting in a substantial economic and social burden.Delivery of drug to particular parts of the anterior or posterior segment has been a major challenge due to various protective barriers and elimination mechanisms associated with the unique anatomical and physiological nature of the ocular system.Drug administration to the eye by conventional delivery systems results in poor ocular bioavailability(<5%).The designing of a novel approach for a safe,simple,and effective ocular drug delivery is a major concern and requires innovative strategies to combat the problem.Over the past decades,several novel approaches involving different strategies have been developed to improve the ocular delivery system.Among these,the ophthalmic in-situ gel has attained a great attention over the past few years.This review discussed and summarized the recent and the promising research progress of in-situ gelling in ocular drug delivery system. 展开更多
关键词 in-situ gel OCULAR Drug delivery BIOAVAILABILITY Polymer CORNEAL RETENTION
下载PDF
Molecular Reactivity and Interface Stability Modification in In-Situ Gel Electrolyte for High Performance Quasi-Solid-State Lithium Metal Batteries 被引量:2
2
作者 Qiyu Wang Xiangqun Xu +4 位作者 Bo Hong Maohui Bai Jie Li Zhian Zhang Yanqing Lai 《Energy & Environmental Materials》 SCIE EI CAS CSCD 2023年第3期8-19,共12页
Quasi-solid-state lithium metal battery is a promising candidate for next generation high energy density and high safety power supply.Despite intensive efforts on electrolytes,uncontrolled interfacial reactions on lit... Quasi-solid-state lithium metal battery is a promising candidate for next generation high energy density and high safety power supply.Despite intensive efforts on electrolytes,uncontrolled interfacial reactions on lithium with electrolyte and patchy interfacial contacts still hinder its practical process.Herein,we bring in rationally designed F contained groups into polymer skeleton via in-situ gelation for the first time to establish quasi-solid-state battery.This method achieves a capacity retention of 90%after 1000 cycles at 0.5C with LiFePO_(4)cathodes.The interface constructed by polymer skeleton and reaction with–CF_(3)lead to the predicted solid electrolyte interface species with high stability.Furthermore,we optimize molecular reactivity and interface stability with regulating F contained end groups in the polymer.Comparisons on different structures reveal that high performance solid stable lithium metal batteries rely on chemical modification as well as stable polymer skeleton,which is more critical to construct robust and steady SEI with uniform lithium deposition.New approach with functional groups regulation proposes a more stable cycling process with a capacity retention of 94.2%at 0.5C and 87.6%at 1C after 1000 cycles with LiFePO_(4) cathodes,providing new insights for the practical development of quasi-solid-state lithium metal battery. 展开更多
关键词 F contained end groups in-situ gel electrolyte interface stability molecular reactivity quasi-solid-state lithium metal battery
下载PDF
Preparation Process of Plumbagin Nanomicelle In-situ Gel
3
作者 Xuemei LU Wanyu ZUO +4 位作者 Yun LI Weiyu WANG Ruyin DONG Luyang LU Jizhong ZHANG 《Medicinal Plant》 2023年第6期35-38,42,共5页
[Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determin... [Objectives]To prepare plumbagin nanomicelle(PLB-N)in-situ gel,and optimize the formulation and process.[Methods]PLB-N was prepared by self-assembly method,and the optimal formulation of PLB-N in-situ gel was determined by orthogonal experiment design and single factor method.[Results]The optimal preparation process for PLB-N was a drug to lipid ratio of 1:3,a Tween 80 content of 5%,an ethanol content of 7.5%of the hydration medium,a magnetic stirring speed of 2200 rpm,a stirring time of 30 min,and an ultrasound time of 10 min.The optimal formulation of PLB-N in-situ gel was 22%of poloxamer 407,6%of poloxamer 188,and 1:1 of PLB-N to water.The encapsulation efficiency of PLB-N prepared with the optimal formula was(95.8%±0.4%),and the average particle size was(75.19±1.14)nm,and the Zeta potential was(-20.73±1.19)mv.[Conclusions]PLB-N in-situ gel had stable and reliable preparation process,uniform content,and broad application prospects. 展开更多
关键词 PLUMBAGIN Nanomicelle in-situ gel Preparation process
下载PDF
Study on Rheology and Release Kinetics of Chuanqi Ophthalmic Microemulsion in situ Gel
4
作者 Maobo DU Yamei LIU +2 位作者 Aiping HE Yao YAO Shuzhi LIU 《Medicinal Plant》 CAS 2018年第2期68-72,共5页
[Objectives] To study the rheology and release kinetics of Chuanqi ophthalmic microemulsion in situ gel,so as to provide references for its future study and development. [Methods]The fluid properties and linear viscoe... [Objectives] To study the rheology and release kinetics of Chuanqi ophthalmic microemulsion in situ gel,so as to provide references for its future study and development. [Methods]The fluid properties and linear viscoelastic regions of this preparation were investigated by MCR 102 rheometer. The release kinetics of Chuanqi ophthalmic microemulsion in situ gel was evaluated by modified Franz diffusion cell method,the ligustrazine and ligustilide were selected as the indictors,and semi-permeable membrane was used as a barrier,sampling time point was 0. 5,1,2,4,6,and 8 h respectively. [Results]Chuanqi ophthalmic microemulsion in situ gel was a pseudoplastic fluid and it had a linear viscoelastic region. Taking the shear stress as the indicator,the linear viscoelastic region was 0-302. 74 Pa; taking the strain as the indicator,the linear viscoelastic region was 0-7. 45%. At the critical point,the storage modulus( G') = the loss modulus( G″) =2 976. 60 Pa,critical shear stress was 302. 74 Pa and critical strain was 7. 45%. The average cumulative release of ligustrazine of 6 samples within 8 h was 33. 71 μg,the average cumulative release rate reached 90. 08%,and the release kinetics followed Higuchi equation. The average cumulative release of ligustilide of 6 samples within 8 h was 68. 46 μg,the average cumulative release rate reached 84. 32%,and the release kinetics followed the zero-order kinetics equation. [Conclusions] Chuanqi ophthalmic microemulsion in situ gel has excellent viscoelasticity and its strain is reversible in a certain range. The release kinetics of ligustrazine is the result from synergistic effect of its physicochemical properties and matrix skeleton,while the release kinetics of ligustilide is mainly affected by its physicochemical properties. 展开更多
关键词 RHEOLOGY Linear viscoelastic region ophthalmic in situ gel MICROEMULSION Chuanqi prescription LIGUSTRAZINE LIGUSTILIDE
下载PDF
A comprehensive review of in-situ polymer gel simulation for conformance control 被引量:4
5
作者 Baojun Bai Jianqiao Leng Mingzhen Wei 《Petroleum Science》 SCIE CAS CSCD 2022年第1期189-202,共14页
Gel treatment has been widely applied in mature oilfields to improve sweep efficiency and control water production.Correct numerical simulation is of major importance to the optimization design and prediction of a suc... Gel treatment has been widely applied in mature oilfields to improve sweep efficiency and control water production.Correct numerical simulation is of major importance to the optimization design and prediction of a successful gel treatment.However,there exist many problems in current simulation studies in published literature.This paper first presents a comprehensive review on the major factors that have been considered at different gelation stages during gel treatment,the models used in the commercial/inhouse simulators,and current numerical simulation studies on both laboratory and field scales.Then we classify the current in-situ gel numerical simulation problems as 1,deficient model problem that has published numerical model but has not been applied in simulator and application studies;2,missing model problem that does not have published quantitative model;and 3,inaccurate application problem that does not consider the major factors of gel performance,based on the reasons from some questionable results of current simulation studies.Finally,we point out the major research efforts that should be made in the future to better simulate in-situ gel treatment process.The review indicates that numerous simulation studies using commercial software packages intend to predigest the gel treatment,many of which,however,ignore important mechanisms and mislead the operation of gel treatment.In fact,a full assessment of simulating in-situ gels cannot be achieved unless the quantitative models can be qualified in terms of transport and plugging mechanisms based on the experimental results. 展开更多
关键词 in-situ gel MECHANISM Simulation model Application studies
下载PDF
Disulfiram thermosensitive in-situ gel based on solid dispersion for cataract 被引量:3
6
作者 Chunjuan Zhang Tonghua Xu +3 位作者 Donglei Zhang Wei He Siling Wang Tongying Jiang 《Asian Journal of Pharmaceutical Sciences》 SCIE CAS 2018年第6期527-535,共9页
To improve the corneal permeability and water-solubility of disulfiram(DSF), which is an ocular drug for cataract, P188 was selected as a matrix to prepare solid dispersion of DSF(DSF SD) by hot melt method. The DSF S... To improve the corneal permeability and water-solubility of disulfiram(DSF), which is an ocular drug for cataract, P188 was selected as a matrix to prepare solid dispersion of DSF(DSF SD) by hot melt method. The DSF SD was characterized by DSC, XRD, and IR, and the results suggested that DSF was amorphous in DSF SD. The DSF SD was added to borate buffer solution(BBS) contained 20% poloxamer P407 and 1.2% poloxamer P188 to form in-situ gel. In vitro and in vivo experiments revealed that DSF SD combined with in-situ gel(DSF SD/in-situ gel) increased the residence time and the amount of DSF penetrated through the corneal. The pharmacodynamics studies exhibited DSF SD/in-situ gel delayed the development of selenium-induced cataract at some content. These results investigated that DSF SD/in-situ gel as a drug delivery system can improve DSF ocular permeability. 展开更多
关键词 DISULFIRAM Solid dispersion in-situ gel PERMEABILITY Anti-cataract
下载PDF
探究重组牛碱性成纤维细胞生长因子眼用凝胶对白内障超声乳化术术后干眼症患者泪膜稳定性、视觉功能的影响
7
作者 张洪勤 陈子林 +2 位作者 范惠雅 黄立嘉 刘云超 《临床和实验医学杂志》 2024年第19期2069-2073,共5页
目的研究重组牛碱性成纤维细胞生长因子(rb-bFGF)眼用凝胶对白内障超声乳化术(CUP)术后干眼症患者的泪膜稳定性和视觉功能的影响。方法前瞻性选取2020年4月至2023年10月惠州市中心人民医院收治的CUP术后并发干眼症患者90例作为研究对象... 目的研究重组牛碱性成纤维细胞生长因子(rb-bFGF)眼用凝胶对白内障超声乳化术(CUP)术后干眼症患者的泪膜稳定性和视觉功能的影响。方法前瞻性选取2020年4月至2023年10月惠州市中心人民医院收治的CUP术后并发干眼症患者90例作为研究对象。按照随机数字表法将其分为观察组和对照组,每组各45例。对照组采用妥布霉素地塞米松滴眼液治疗,观察组在其基础上联合rb-bFGF眼用凝胶治疗。比较两组治疗疗效。观察两组患者治疗前、治疗4周后的泪膜稳定性[泪膜破裂时间(BUT)、基础泪液分泌试验(SIT)、角膜荧光素染色(FL)评分],治疗前、治疗2周、治疗4周后的视觉功能情况,并观察两组患者治疗前、治疗4周后的炎症指标[白细胞介素(IL)-1β、IL-8]、应激指标[脂质过氧化物(LPO)、丙二醇]变化,并比较两组的安全性。结果治疗后,观察组治疗总有效率为95.56%,高于对照组(82.22%),差异有统计学意义(P<0.05)。观察组治疗4周后的BUT、SIT分别为(8.64±0.92)s、(10.26±0.47)mm/5 min,均高于对照组[(7.83±0.44)s、(8.63±1.87)mm/5 min],FT评分为(0.84±0.17)分,低于对照组[(1.31±0.25)分],差异均有统计学意义(P<0.05)。观察组治疗2、4周后的视力分别为0.64±0.11、0.81±0.05,均高于对照组(0.54±0.09、0.75±0.11),差异均有统计学意义(P<0.05)。观察组治疗4周后的血清IL-1β、IL-8、丙二醇、LPO水平分别为(38.22±3.59)ng/L、(64.87±8.46)ng/L、(2.75±0.55)U/L、(1.43±0.15)μmol/L,均低于对照组[(77.15±9.25)ng/L、(96.06±10.34)ng/L、(3.29±0.12)U/L、(1.92±0.22)μmol/L],差异均有统计学意义(P<0.05)。观察组与对照组的不良反应总发生率比较(6.67%vs.4.44%),差异无统计学意义(P>0.05)。结论在CUP术后干眼症患者的临床治疗中,使用rb-bFGF眼用凝胶辅助治疗可显著提高其泪膜稳定性,促进视觉功能的恢复。 展开更多
关键词 重组牛碱性成纤维细胞生长因子眼用凝胶 白内障超声乳化术后 干眼症 泪膜稳定性 视觉功能
下载PDF
加替沙星眼用凝胶治疗细菌性结膜炎可行性分析
8
作者 王英 《中华灾害救援医学》 2024年第5期599-601,共3页
目的探究加替沙星眼用凝胶临床上用于治疗细菌性结膜炎的可行性。方法选取2022年11月至2023年11月六盘水市妇幼保健院眼科收治的118例细菌性结膜炎患者为研究对象,随机数字分为观察组(加替沙星眼用凝胶,n=59)和对照组(左氧氟沙星眼用凝... 目的探究加替沙星眼用凝胶临床上用于治疗细菌性结膜炎的可行性。方法选取2022年11月至2023年11月六盘水市妇幼保健院眼科收治的118例细菌性结膜炎患者为研究对象,随机数字分为观察组(加替沙星眼用凝胶,n=59)和对照组(左氧氟沙星眼用凝胶,n=59)。观察两组患者的临床有效率、细菌清除率,监测治疗期间不良反应的发生情况。结果14天治疗后,两组患者临床症状和体征均减轻,观察组患者改善更明显(94.92%vs 81.36%,χ^(2)=5.187,P=0.023);两组患者细菌感染率均降低,观察组细菌清除率更明显(91.53%vs 74.57%,χ^(2)=6.020,P=0.014);观察组患者不良反应发生率为1.69%,与对照组的3.39%无显著差异(P=0.559)。结论加替沙星眼用凝胶用于治疗细菌性结膜炎具有疗效好、抗菌活性强、安全性高的优点。 展开更多
关键词 加替沙星眼用凝胶 细菌性结膜炎 有效性研究
下载PDF
更昔洛韦眼用凝胶与干扰素滴眼液治疗小儿单疱病毒性角膜炎的效果探究
9
作者 潘玉 《中国实用医药》 2024年第19期138-141,共4页
目的 评定更昔洛韦眼用凝胶与干扰素滴眼液治疗小儿单纯疱疹(单疱)病毒性角膜炎的效果。方法 100例小儿单疱病毒性角膜炎患儿,以计算机随机化方法分为对照组与试验组,每组50例。对照组患儿应用干扰素滴眼液治疗,试验组患儿应用更昔洛韦... 目的 评定更昔洛韦眼用凝胶与干扰素滴眼液治疗小儿单纯疱疹(单疱)病毒性角膜炎的效果。方法 100例小儿单疱病毒性角膜炎患儿,以计算机随机化方法分为对照组与试验组,每组50例。对照组患儿应用干扰素滴眼液治疗,试验组患儿应用更昔洛韦眼用凝胶联合干扰素滴眼液治疗。比较两组患儿治疗效果,症状消退时间,视力水平,炎性因子指标[C反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-8(IL-8)、干扰素-α(IFN-α)]水平及不良反应发生情况。结果 试验组总有效率(98.00%)较对照组(84.00%)更高(P<0.05)。试验组眼部刺激征、溃疡、角膜充血消退时间分别为(6.50±1.22)、(12.51±5.32)、(7.01±1.44)d,均短于对照组的(10.41±2.50)、(21.08±4.65)、(12.38±2.30)d(P<0.05)。治疗后,两组视力、INF-α水平均高于治疗前, CRP、TNF-α、IL-8水平均低于治疗前,且试验组视力(0.95±0.13)、INF-α(118.20±9.83)ng/L较对照组的(0.80±0.12)、(87.64±7.25)ng/L更高, CRP(3.44±0.10)mg/L、TNF-α(29.53±9.20)ng/L、IL-8(49.63±6.05)ng/L较对照组的(8.62±0.75)mg/L、(44.08±8.46)ng/L、(70.22±4.76)ng/L更低(P<0.05)。试验组不良反应发生率(6.00%)与对照组(8.00%)比较差异较小(P>0.05)。结论 小儿单疱病毒性角膜炎患儿接受更昔洛韦眼用凝胶联合干扰素滴眼液方案治疗,能获取较好的效果,缩短康复的时间,更好地改善炎性因子指标水平,且不会增加不良反应的发生几率,意义重大。 展开更多
关键词 小儿单纯疱疹病毒性角膜炎 更昔洛韦眼用凝胶 干扰素滴眼液
下载PDF
SiO_(2) nanofiber composite gel polymer electrolyte by in-situ polymerization for stable Li metal batteries 被引量:3
10
作者 Zhichuan Shen Jiawei Zhong +5 位作者 Jiahong Chen Wenhao Xie Kun Yang Yuhan Lin Jinbiao Chen Zhicong Shi 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第3期536-540,共5页
Gel polymer electrolytes(GPEs) are promising alternatives to liquid electrolytes applied in high-energydensity batteries.Here superior SiO_(2) nanofiber composite gel polymer electrolytes(SNCGPEs) are developed via in... Gel polymer electrolytes(GPEs) are promising alternatives to liquid electrolytes applied in high-energydensity batteries.Here superior SiO_(2) nanofiber composite gel polymer electrolytes(SNCGPEs) are developed via in-situ ionic ring-opening polymerization of 1,3-dioxolane(DOL) monomers in SiO_(2) nanofiber membrane(PDOL-SiO_(2)) for lithium metal batteries.The oxygen atoms of PDOL together with Si-O of SiO_(2) construct a more efficient channel for Li^(+) migration.Consequently,the lithium ion transference number(t_(Li^(+)) and ionic conductivity(σ) at 30℃ of PDOL-SiO_(2) are 0.80 and 1.68×10^(-4)S/cm separately.PDOL-SiO_(2) manifests the electrochemical decomposition potentials of 4.90 V.At 0.5 mA/cm^(2),Li|PDOL-SiO_(2) |Li cell shows a steady cycling performance for nearly 1400 h.LFP|PDOL-SiO_(2) |Li battery can steadily cycle at 0.5 C with a capacity retention rate of 89% after 200 cycles.While cycling at 2 C,the capacity retention rate can maintain at 78% after 300 cycles.This contribution provides a innovative strategy for accelerating Li^(+)transportation via designing PDOL molecular chains throughout the SiO_(2) nanofiber framework,which is crucial for high-energy-density LMBs. 展开更多
关键词 SiO_(2)nanofiber in-situ polymerization Composite gel polymer electrolytes 1 3-Dioxolane Lithium metal-LFP battery
原文传递
三七总皂苷眼用凝胶在兔眼部的组织分布研究
11
作者 王仁兴 张奎斌 +2 位作者 王敏 胡远康 刘志东 《天津中医药大学学报》 CAS 2023年第2期230-235,共6页
[目的]研究三七总皂苷眼用凝胶在兔眼组织的药物分布。[方法]选取12只新西兰大白兔,随机分为4组,每组3只兔子。每只兔眼分别给予凝胶41.67μL/kg(即三七皂苷R1 0.132 mg/kg,人参皂苷Rg1 0.452 mg/kg)。给药后于0.5、1、1.5、2 h空气栓... [目的]研究三七总皂苷眼用凝胶在兔眼组织的药物分布。[方法]选取12只新西兰大白兔,随机分为4组,每组3只兔子。每只兔眼分别给予凝胶41.67μL/kg(即三七皂苷R1 0.132 mg/kg,人参皂苷Rg1 0.452 mg/kg)。给药后于0.5、1、1.5、2 h空气栓塞各处死1组兔子。取眼球,分离各眼组织。采用UPLC-MS检测不同时间点各眼组织的药物含量。[结果]兔眼给予三七总皂苷眼用凝胶后,三七皂苷R1在兔角膜、晶状体、房水、玻璃体中的最大含量分别为13.16、1.16、0.86、0.10μg/g,人参皂苷Rg1在角膜、晶状体、房水、玻璃体中的最大含量分别为38.49、4.50、3.38、0.28μg/g。[结论]三七总皂苷眼用凝胶滴到兔眼后,三七皂苷R1和人参皂苷Rg1可透过角膜分散到各眼组织。在0~2 h内,各眼组织中的药物含量由高到低依次为角膜、晶状体、房水、玻璃体,表明三七皂苷R1和人参皂苷Rg1可透过角膜,到达眼后部组织,在2 h时各眼部组织的药物含量依然较高,在眼组织的保留时间长。 展开更多
关键词 三七皂苷R1 人参皂苷RG1 眼用凝胶 组织分布
下载PDF
维生素A棕榈酸酯眼用凝胶辅助治疗白内障术后干眼症的效果及其对泪液炎症因子的影响 被引量:3
12
作者 杨晓鸽 李萌 刘娟 《海南医学》 CAS 2023年第6期805-808,共4页
目的探讨维生素A棕榈酸酯眼用凝胶辅助治疗白内障术后干眼症的效果及其对泪液炎症因子的影响。方法选取2019年3月至2021年2月在渭南市第二医院治疗的94例白内障术后干眼症患者为研究对象,依据随机数表法分为对照组和研究组各47例。对照... 目的探讨维生素A棕榈酸酯眼用凝胶辅助治疗白内障术后干眼症的效果及其对泪液炎症因子的影响。方法选取2019年3月至2021年2月在渭南市第二医院治疗的94例白内障术后干眼症患者为研究对象,依据随机数表法分为对照组和研究组各47例。对照组患者使用玻璃酸钠滴眼液治疗,研究组患者在对照组治疗的基础上使用维生素A棕榈酸酯眼用凝胶治疗。治疗30 d后,比较两组患者的临床疗效、治疗前后的泪液炎症因子水平[包括肿瘤坏死因子-α(TNF-α)、白细胞介素-1β(IL-1β)]、干眼症状评分及视觉相关生存质量评分。结果研究组患者的治疗总有效率为91.49%,明显高于对照组的74.47%,差异有统计学意义(P<0.05);治疗前,两组患者的TNF-α、IL-1β水平比较差异均无统计学意义(P>0.05);治疗后,研究组患者的TNF-α、IL-1β水平分别为(133.94±12.26)ng/L、(34.20±5.66)ng/L,明显低于对照组的(239.15±26.39)ng/L、(67.42±5.49)ng/L,差异均有统计学意义(P<0.05);治疗前,两组患者的干眼症状评分比较差异无统计学意义(P>0.05);治疗后,研究组患者的干眼症状评分为(0.81±0.19)分,明显低于对照组的(1.70±0.31)分,差异有统计学意义(P<0.05);治疗前,两组患者的心理健康、社会活动、眼痛、一般健康评分比较差异均无统计学意义(P>0.05);治疗后,研究组患者的心理健康、社会活动、眼痛、一般健康评分分别为(73.77±4.92)分、(72.35±5.34)分、(76.32±4.92)分、(64.35±5.90)分,明显高于对照组的(65.39±5.61)分、(64.43±3.26)分、(60.31±4.23)分、(58.36±4.32)分,差异均有统计学意义(P<0.05)。结论维生素A棕榈酸酯眼用凝胶辅助治疗白内障术后干眼症疗效显著,同时可显著改善患者泪液炎症因子水平,提高生活质量。 展开更多
关键词 干眼症 维生素A棕榈酸酯眼用凝胶 白内障术 临床疗效 肿瘤坏死因子-α 白细胞介素-1Β 生存质量
下载PDF
Determination of drug concentration in aqueous humor of cataract patients administered gatifloxacin ophthalmic gel 被引量:2
13
作者 LIU Xuan WANG Ning-li +6 位作者 WANG Yan-ling MA Chen MA Li GAO Li-xin HUANG Ying-xiang XIONG Shi-hong WANG Kang 《Chinese Medical Journal》 SCIE CAS CSCD 2010年第15期2105-2110,共6页
Background Ophthalmic gel has been developed to increase the drug concentration in aqueous humor and to retard the loss of drug from the conjunctival sac.The research was to compare the drug concentration in aqueous h... Background Ophthalmic gel has been developed to increase the drug concentration in aqueous humor and to retard the loss of drug from the conjunctival sac.The research was to compare the drug concentration in aqueous humor of cataract patients administered 0.3% gatifloxacin ophthalmic gel with that in patients administered 0.3% gatifloxacin ophthalmic solution.Methods Ninety-six patients with cataract (96 eyes) were randomly assigned to 8 groups.The patients in groups 1-4received topical gatifloxacin 0.3% ophthalmic gel and those in groups 5-8 received gatifloxacin 0.3% ophthalmic solution.The dose regimen was 1 drop, 4 times a day for 3 consecutive days prior to cataract surgery.On the day of surgery, 1drop was applied at 15, 30, 60 or 120 minutes before commencement of cataract surgery in groups 1 and 5, groups 2 and 6, goups 3 and 7, and groups 4 and 8, respectively.Aqueous humor was extracted during the cataract surgery for the analysis of gatifloxacin concentration..Results The concentrations of gatifloxacin in aqueous humor were (0.24±0.25) μg/ml, (1.11±0.74) μg/ml, (2.32±2.01)μg/ml and (1.85±1.14) μg/ml in groups 1 to 4, and (0.16±0.25) μg/ml, (0.31±0.24) μg/ml, (0.75±0.28) μg/ml and (0.33±0.22) μg/ml in groups 5 to 8, respectively.Patients receiving gatifloxacin ophthalmic gel showed greater mean values of gatifloxacin concentration in aqueous humor than those receiving gatifloxacin solution, and such differences were significant with P 〈0.05 for all comparisons except that between groups 1 and 5.Conclusion Topical gatifloxacin ophthalmic gel can attain significantly greater drug concentrations in human aqueous humor than gatifloxacin ophthalmic solution. 展开更多
关键词 gatifloxacin ophthalmic gel ENDophthalmITIS cataract surgery QUINOLONES
原文传递
维生素A棕榈酸酯眼用凝胶联合地夸磷索钠滴眼液治疗白内障超声乳化术后干眼的临床研究 被引量:1
14
作者 殷丽 姚勇 《南通大学学报(医学版)》 2023年第2期137-140,共4页
目的:分析维生素A棕榈酸酯眼用凝胶联合地夸磷索钠滴眼液治疗白内障超声乳化术后干眼的临床效果。方法:选取南京医科大学附属无锡人民医院2021年1—12月就诊的白内障超声乳化术后干眼患者118例,按随机数字表法分成对照组59例、观察组59... 目的:分析维生素A棕榈酸酯眼用凝胶联合地夸磷索钠滴眼液治疗白内障超声乳化术后干眼的临床效果。方法:选取南京医科大学附属无锡人民医院2021年1—12月就诊的白内障超声乳化术后干眼患者118例,按随机数字表法分成对照组59例、观察组59例。对照组接受维生素A棕榈酸酯眼用凝胶治疗,观察组在对照组基础上予地夸磷索钠滴眼液治疗,均治疗8周。对比两组治疗前后泪液浸湿长度、角膜荧光素染色(fluorescein staining,FL)评分、睑板腺腺体完整度、IL-1β与TNF-α水平,比较两组临床疗效与不良反应。结果:两组临床疗效等级比较差异有统计学意义(P<0.05);两组治疗前泪液浸湿长度、FL评分、睑板腺腺体完整度评分、IL-1β、TNF-α水平比较差异均无统计学意义(均P>0.05),治疗后两组泪液浸湿长度均高于治疗前(均P<0.05),FL评分、IL-1β、TNF-α水平均低于治疗前(均P<0.05),且观察组泪液浸湿长度、睑板腺腺体完整度评分均高于对照组(均P<0.05),FL评分、IL-1β、TNF-α水平均低于对照组(均P<0.05);两组不良反应总发生率对比差异无统计学意义(P>0.05)。结论:维生素A棕榈酸酯眼用凝胶联合地夸磷索钠滴眼液治疗白内障超声乳化术后干眼的疗效确切,可减少角膜损伤,增加泪液分泌,保护睑板腺腺体完整度,减轻眼表炎症反应,且安全可靠。 展开更多
关键词 白内障 维生素A棕榈酸酯眼用凝胶 地夸磷索钠滴眼液 超声乳化术 干眼
下载PDF
离子敏感型原位凝胶在眼部给药的应用
15
作者 刘颖慧 李昆钊 +1 位作者 梁文迪 王东凯 《中国药剂学杂志(网络版)》 2023年第3期166-174,共9页
目的综述离子敏感型原位凝胶在眼部给药的应用。方法查阅近些年国内外关于眼用离子敏感型原位凝胶的相关文献,并对其进行归纳、整理和总结。结果原位凝胶具有滴眼液和眼用凝胶剂的双重优势,能够克服传统眼用剂型的局限性,延长药物在角... 目的综述离子敏感型原位凝胶在眼部给药的应用。方法查阅近些年国内外关于眼用离子敏感型原位凝胶的相关文献,并对其进行归纳、整理和总结。结果原位凝胶具有滴眼液和眼用凝胶剂的双重优势,能够克服传统眼用剂型的局限性,延长药物在角膜的滞留时间,减少给药次数,提高生物利用度,增强患者依从性。结论眼用原位凝胶制剂具有独特的优势,在治疗眼部疾病方面有着巨大的潜力和广阔的前景。 展开更多
关键词 原位凝胶 离子敏感 结冷胶 海藻酸盐 眼用制剂
下载PDF
小切口摘除术治疗老年性硬核性白内障中眼用凝胶的应用效果
16
作者 宋雨晨 香淑媚 李伟勋 《实用临床医药杂志》 CAS 2023年第4期66-69,共4页
目的 探讨小切口摘除术联合术后小牛血去蛋白提取物(DCBE)眼用凝胶治疗老年性硬核性白内障的效果。方法 采取前瞻性研究选取老年性硬核性白内障患者94例(108眼),随机数字表法分为观察组和对照组,每组47例。对照组采取小切口摘除术,观察... 目的 探讨小切口摘除术联合术后小牛血去蛋白提取物(DCBE)眼用凝胶治疗老年性硬核性白内障的效果。方法 采取前瞻性研究选取老年性硬核性白内障患者94例(108眼),随机数字表法分为观察组和对照组,每组47例。对照组采取小切口摘除术,观察组患者在对照组基础上联合DCBE眼用凝胶治疗,2组均治疗1周。随访3个月,比较2组患者视力、散光程度、术后疗效、泪液分泌、泪膜破裂时间、角膜荧光染色评分、血清β2微球蛋白(β2-MG)、炎症因子水平以及并发症等差异。结果 观察组患者术后4、8、12周的视力量表评分高于对照组,差异有统计学意义(P<0.05)。术前以及术后1、4、8、12周患者的散光情况比较,差异无统计学意义(P>0.05)。2组治疗效果评分均升高,且观察组术后1、4周的治疗效果评分低于对照组,差异有统计学意义(P<0.05)。观察组术后1、4周泪液分泌长度大于对照组,差异有统计学意义(P<0.05)。观察组患者术后1、4周的泪膜破裂时间长于对照组,差异有统计学意义(P<0.05)。观察组患者超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)水平以及β2-MG水平低于对照组,差异有统计学意义(P<0.05)。2组患者角膜水肿、一过性高眼压、瞳孔变形以及房水浑浊比较,差异无统计学意义(P>0.05)。结论 老年性硬核性白内障患者采取小切口摘除术联合术后DCBE眼用凝胶治疗安全、有效,可显著下调血清β2-MG、炎症因子水平。 展开更多
关键词 硬核性白内障 小切口摘除术 小牛血清去蛋白眼用凝胶 Β2微球蛋白 视力 炎症因子
下载PDF
小牛血去蛋白提取物眼用凝胶联合妥布霉素地塞米松滴眼液治疗女性白内障术后角膜水肿的临床效果
17
作者 张述娟 周浩 《妇儿健康导刊》 2023年第14期108-110,共3页
目的研究女性白内障术后角膜水肿患者运用小牛血去蛋白提取物眼用凝胶联合妥布霉素地塞米松滴眼液治疗的效果。方法选择2021年3月至2022年8月在兰陵县人民医院治疗的女性白内障术后角膜水肿患者84例,以随机数字表法分为研究组和对照组,... 目的研究女性白内障术后角膜水肿患者运用小牛血去蛋白提取物眼用凝胶联合妥布霉素地塞米松滴眼液治疗的效果。方法选择2021年3月至2022年8月在兰陵县人民医院治疗的女性白内障术后角膜水肿患者84例,以随机数字表法分为研究组和对照组,每组42例。对照组给予妥布霉素地塞米松滴眼液治疗,研究组给予小牛血去蛋白提取物眼用凝胶联合妥布霉素地塞米松滴眼液治疗,比较两组患者的临床疗效、视力水平、不良反应。结果与对照组比较,研究组临床疗效更高,治疗后视力水平更高,不良反应总发生率更低,差异有统计学意义(P<0.05)。结论女性白内障术后角膜水肿患者运用小牛血去蛋白提取物眼用凝胶联合妥布霉素地塞米松滴眼液治疗,效果显著,可进一步改善患者视力水平,降低不良反应发生率。 展开更多
关键词 白内障 角膜水肿 小牛血去蛋白提取物眼用凝胶 妥布霉素地塞米松滴眼液 临床疗效
下载PDF
阿昔洛韦眼用凝胶基质对兔疱疹性角膜炎药效的影响 被引量:17
18
作者 何群 张明亮 +2 位作者 张湘晖 谭海波 李智勇 《中国医院药学杂志》 CAS CSCD 北大核心 2003年第5期262-264,共3页
目的:通过药效试验论证卡波姆凝胶用作阿昔洛韦眼膏基质的可行性。方法:选用市售阿昔洛韦眼膏作为对照组,阿昔洛韦眼用凝胶剂为实验组,比较两者治疗实验性家兔单纯疱疹性角膜炎的药效差异。结果:实践组与对照组皆在平均治疗9d后角膜病... 目的:通过药效试验论证卡波姆凝胶用作阿昔洛韦眼膏基质的可行性。方法:选用市售阿昔洛韦眼膏作为对照组,阿昔洛韦眼用凝胶剂为实验组,比较两者治疗实验性家兔单纯疱疹性角膜炎的药效差异。结果:实践组与对照组皆在平均治疗9d后角膜病变减轻;两组有效时间差异无显著性(P>0.05)。结论:卡波姆凝胶对阿昔洛韦治疗实验性家兔单纯疱疹性角膜炎的药效与油性基质相同,无干扰作用,不影响主药发挥疗效,可用作该眼膏的基质。 展开更多
关键词 阿昔洛韦眼用凝胶基质 疱疹性角膜炎 药效 影响
下载PDF
左氧氟沙星热敏型眼用凝胶的研制及体外释放研究 被引量:42
19
作者 高斐 王东凯 +3 位作者 罗立 徐松林 刘莱 徐飒 《中国药房》 CAS CSCD 北大核心 2005年第14期1057-1059,共3页
目的:制备左氧氟沙星热敏型眼用凝胶,并对其体外释放行为进行考察。方法:以泊洛沙姆407为热敏型材料制备左氧氟沙星眼用凝胶,根据胶凝温度筛选泊洛沙姆407的最佳处方浓度,采用无膜溶出模型对该制剂的体外释放行为进行考察。结果:左氧氟... 目的:制备左氧氟沙星热敏型眼用凝胶,并对其体外释放行为进行考察。方法:以泊洛沙姆407为热敏型材料制备左氧氟沙星眼用凝胶,根据胶凝温度筛选泊洛沙姆407的最佳处方浓度,采用无膜溶出模型对该制剂的体外释放行为进行考察。结果:左氧氟沙星检测浓度线性范围为3~11μg/ml(r=0.9991,n=6),回收率为99.62%;泊洛沙姆407在处方中的最佳浓度为18%;药物释放呈零级动力学特征,释放量取决于凝胶溶蚀量。结论:该制剂制备方法简单,用药剂量易于控制,极具开发前景。 展开更多
关键词 左氧氟沙星 泊洛沙姆407 热敏型眼用凝胶 体外释放 无膜溶出模型
下载PDF
微渗析技术研究依诺沙星眼用缓释凝胶剂兔眼内药动学 被引量:7
20
作者 刘志东 李佳玮 +3 位作者 张立波 苏龙 丁平田 潘卫三 《中国新药杂志》 CAS CSCD 北大核心 2005年第7期867-869,共3页
目的:研究依诺沙星家兔眼内药动学。方法:采用微渗析技术进行依诺沙星眼用缓释凝胶剂在体药动学的研究,数据经非隔室模型处理,以方差分析和双单侧t检验评价各参数。结果:眼用缓释凝胶剂的药动学参数为:AUC=(1·615±0·900)... 目的:研究依诺沙星家兔眼内药动学。方法:采用微渗析技术进行依诺沙星眼用缓释凝胶剂在体药动学的研究,数据经非隔室模型处理,以方差分析和双单侧t检验评价各参数。结果:眼用缓释凝胶剂的药动学参数为:AUC=(1·615±0·900)μg·h·mL-1,Cmax=(2·726±1·790)μg·mL-1,Tmax=(0·33±0·24)h,Ke=(0·270±0·140);滴眼液的药动学参数为:AUC=(0·414±0·210)μg·h·mL-1,Cmax=(0·689±0·890)μg·mL-1,Tmax=(0·25±0·10)h,Ke=(0·548±0·500)。结论:眼用缓释凝胶剂明显提高了药物在眼内的生物利用度,并且延长了作用时间,达到了缓释制剂的设计要求。 展开更多
关键词 依诺沙星 微渗析技术 眼用缓释凝胶剂 药物动力学
下载PDF
上一页 1 2 12 下一页 到第
使用帮助 返回顶部